Hosted by CPI, Imperial College London, and The BioIndustry Association (BIA), the 4th annual RNA Vaccines and Therapeutics Conference recently took place in London on the 15-16th September 2026, bringing together a diverse range of academic and industry experts. The symposium featured excellent talks on recent successes and challenges in developing the next generation of RNA vaccines, as well as an engaging panel discussion on the future of RNA medicines for cancer treatment and a poster session.
Our RSC Pharmaceutics Editor-in-Chief, Professor Yvonne Perrie, attended this conference, and RSC Pharmaceutics was delighted to sponsor three poster prizes to celebrate the outstanding work of researchers in the field, namely Thomas Payne (Monash University), Lauren Wright (The University of Sheffield) and Umair Shah (Moderna).

Professor Yvonne Perrie from the University of Strathclyde, Thomas Payne from Monash University, Lauren Wright from The University of Sheffield, Dr Lorna McInroy from Moderna on behalf of Umair Shah, and Dr Chloe Johnson from the Royal Society of Chemistry. Not pictured: Umair Shah from Moderna.
We are delighted that the conference was such a success and we would like to wish a huge congratulations to the poster prize winners!
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Submit to RSC Pharmaceutics today!
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.




RSC Pharmaceutics poster prize winner: Jakub Hanczak (Imperial College London)
RSC Pharmaceutics poster prize winner: Hadijatou Sallah (Imperial College London)
RSC Pharmaceutics poster prize winner: Piyush Chaturbedy (TTP plc)

